Explore more publications!

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cogent Communications Holdings, Inc. - CCOI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ultragenyx Pharmaceutical Inc. – RARE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of T1 Energy Inc. - TE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutanix, Inc. - NTNX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Corcept Therapeutics Incorporated – CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apogee Enterprises, Inc. - APOG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Carvana Co. - CVNA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
Houzeo Names Illinois’s Best Places to Live in 2026 Using Comprehensive Housing and Economic Data
Raynet expands Raynet One with AI-powered Software Asset Management
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ashford Hospitality Trust, Inc. - AHT
Influential Women Spotlights Melissa J. Smith, Chicago-Based Sales Enablement & B2B AI Leader Driving Business Growth
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zenas BioPharma, Inc. – ZBIO
Institute of Medicine of Chicago Welcomes Archana Chatterjee, MD, PhD,  & Beena Peters, DNP, RN, as New Officers
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Beta Bionics, Inc. - BBNX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
Marquette National Corporation Increases Quarterly Dividend 6.5 Percent
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
Hanmi Financial Increases Cash Dividend 4% to $0.28 per share and Expands Repurchase Authorization

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions